Ingo Konetzki

This inventor holds 33 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 27 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2005-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingo Konetzki. Retrieved from https://idiyas.com/inventor/ingo-konetzki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 27 (Patent Applications = 13)

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 172(Granted Patents)

Location History:

Warthausen, DE (2005 - 2014)
Aachen-Oberforstbach, DE (2013 - 2015)

Company Filing History:

25 out of 1,561

Boehringer Ingelheim International Gmbh

patents

8 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 2005-2015

Loading Chart...

Areas of Expertise:

Bradykinin Antagonists

Beta Agonists

Pharmaceutical Compositions

Respiratory Diseases

Chronic Obstructive Pulmonary Disease

Betamimetics

Medicaments

Enantiomerically Pure Compounds

Cycloalkyl Derivatives

Long Acting

Tiotropium

Drug Combinations

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9029544 - Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation (2015-05-12),

2. 8916589 - Bradykinin B1-antagonists (2014-12-23),

3. 8865702 - B1-antagonists (2014-10-21),

4. 8450306 - Bradykinin B1-receptor antagonists (2013-05-28),

5. 8394805 - Compounds (2013-03-12),

6. 8372838 - Compounds as bradykinin B1 antagonists (2013-02-12),

7. 8252785 - Aryl sulfonamides as bradykinin-B1-receptor antagonists (2012-08-28),

8. 8044046 - Medicaments for the treatment of chronic obstructive pulmonary disease (2011-10-25),

9. 8034809 - Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments (2011-10-11),

10. 7858618 - Compounds (2010-12-28),

11. 7786111 - Medicaments for the treatment of chronic obstructive pulmonary disease (2010-08-31),

12. 7754756 - Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions (2010-07-13),

13. 7727984 - Medicaments for the treatment of chronic obstructive pulmonary disease (2010-06-01),

14. 7709474 - Enantiomerically pure beta agonists, manufacturing and use thereof (2010-05-04),

15. 7632834 - Long acting beta-2-agonists and their use as medicaments (2009-12-15),

Title: The Innovative Mind of Ingo Konetzki

Introduction: Ingo Konetzki, a pioneering inventor hailing from Warthausen, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ingo Konetzki's latest patents showcase his ingenuity and forward-thinking approach to problem-solving in various industries, including telecommunications, renewable energy, and healthcare.

Career Highlights: Throughout his illustrious career, Ingo Konetzki has consistently pushed the boundaries of innovation, with a keen focus on developing cutting-edge solutions that have revolutionized the way we live and work. His passion for creating impactful inventions has earned him recognition as a trailblazer in the world of technology.

Collaborations: Ingo Konetzki has collaborated with leading research institutions, universities, and multinational corporations to bring his visionary ideas to life. His ability to work seamlessly with diverse teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: In conclusion, Ingo Konetzki's unwavering dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His remarkable contributions continue to inspire future generations of inventors and shape the landscape of technological advancement.

Profile summary based on public USPTO records.